Skip to content

A new technique for noninvasive prenatal testing of hereditary deafness based on a different haplotype analysis strategy

A new technique for noninvasive prenatal testing of hereditary deafness based on a different haplotype analysis strategy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057007
Enrollment
Unknown
Registered
2022-02-25
Start date
2022-02-10
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deaf

Interventions

Index test:Sanger sequencing of GJB2 and SLC26A4.
Gold Standard:Fetal DNA was obtained by invasive prenatal testing such as amniocentesis.

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. The probands of deafness families had definite deafness causative genes (GJB2, SLC26A4); 2. Couples were determined to have a deafness conflict genotype; 3. Both couples were carriers of common deafness genes (GJB2, SLC26A4).

Exclusion criteria

Exclusion criteria: 1. The mother herself is known to have chromosomal number or structural abnormalities; 2. Received exogenous blood transfusion, stem cell transplantation, immunotherapy within 1 year; 3. With comorbid tumor carriage; 4. Those who could not complete prenatal diagnosis on request; 5. With multiple gestations.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;

Countries

China

Contacts

Public ContactJiang Yi

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

dr.jiangyi@163.com+86 15900898902

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026